Cancer Research The Future of Cancer Research: Science and Patient Impact Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
[Cancer Research 57, 3537-3547, August 15, 1997]
© 1997 American Association for Cancer Research
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kool, M.
Right arrow Articles by Borst, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kool, M.
Right arrow Articles by Borst, P.

Analysis of Expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, Homologues of the Multidrug Resistance-associated Protein Gene (MRP1), in Human Cancer Cell Lines1

Marcel Kool, Marcel de Haas, George L. Scheffer, Rik J. Scheper, Michiel J.T. van Eijk, Jenneke A. Juijn, Frank Baas and Piet Borst2

Division of Molecular Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam [M. K., M. d. H., P. B.]; Department of Pathology, Free University Hospital, 1081 HV Amsterdam [G. L. S., R. J. S.]; Department of Pediatric Gastroenterology and Laboratory for Metabolic Diseases, Wilhelmina Children's Hospital, 3501 CA Utrecht [M. J. T. v. E., J. A. J.]; and Department of Neurology, Academic Medical Center, 1105 AZ Amsterdam [F. B.], the Netherlands

By screening databases of human expressed sequence tags, we have identified three new homologues of MRP1, the gene encoding the multidrug resistance-associated protein, and cMOAT (or MRP2), the canalicular multispecific organic anion transporter gene. We call these new genes MRP3, MRP4, and MRP5. MRP3, like cMOAT, is mainly expressed in the liver. MRP4 is expressed only at very low levels in a few tissues, and MRP5, like MRP1, is expressed in almost every tissue tested. To assess a possible role of these new MRP homologues in multidrug or cisplatin resistance, a large set of resistant cell lines was examined for the (over)expression of MRP1, cMOAT, MRP3, MRP4, and MRP5. We find that even in cells selected for a low level of resistance, several MRP-related genes can be up-regulated simultaneously. However, MRP4 is not overexpressed in any of the cell lines we analyzed; MRP3 and MRP5 are only overexpressed in a few cell lines, and the RNA levels do not seem to correlate with resistance to either doxorubicin or cisplatin. cMOAT is substantially overexpressed in several cell lines, and cMOAT RNA levels correlate with cisplatin but not doxorubicin resistance in a subset of resistant cell lines. Our results emphasize the need for gene-specific blocks in gene expression to define which transporter contributes to resistance in each resistant cell line.

1 This work was supported by a grant from the Dutch Cancer Society (to F. B. and P. B.).

2 To whom requests for reprints should be addressed. Phone: 31-20-5122880; Fax: 31-20-6691383.

Received 1/27/97. Accepted 6/11/97.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
Md. T. Hoque and S. P.C. Cole
Down-regulation of Na+/H+ Exchanger Regulatory Factor 1 Increases Expression and Function of Multidrug Resistance Protein 4
Cancer Res., June 15, 2008; 68(12): 4802 - 4809.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Y. Chen, Y. Tang, M.-T. Wang, S. Zeng, and D. Nie
Human Pregnane X Receptor and Resistance to Chemotherapy in Prostate Cancer
Cancer Res., November 1, 2007; 67(21): 10361 - 10367.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
I. J. Letourneau, A. J. Slot, R. G. Deeley, and S. P. C. Cole
Mutational Analysis of a Highly Conserved Proline Residue in MRP1, MRP2, and MRP3 Reveals a Partially Conserved Function
Drug Metab. Dispos., August 1, 2007; 35(8): 1372 - 1379.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
H. K. Choi, J. W. Yang, S. H. Roh, C. Y. Han, and K. W. Kang
Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells
Endocr. Relat. Cancer, June 1, 2007; 14(2): 293 - 303.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
T. Imaoka, H. Kusuhara, M. Adachi, J. D. Schuetz, K. Takeuchi, and Y. Sugiyama
Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir
Mol. Pharmacol., February 1, 2007; 71(2): 619 - 627.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
P. Surowiak, V. Materna, I. Kaplenko, M. Spaczynski, B. Dolinska-Krajewska, E. Gebarowska, M. Dietel, M. Zabel, and H. Lage
ABCC2 (MRP2, cMOAT) Can Be Localized in the Nuclear Membrane of Ovarian Carcinomas and Correlates with Resistance to Cisplatin and Clinical Outcome
Clin. Cancer Res., December 1, 2006; 12(23): 7149 - 7158.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
R. G. Deeley, C. Westlake, and S. P. C. Cole
Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins.
Physiol Rev, July 1, 2006; 86(3): 849 - 899.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. J. Bachmeier, W. J. Trickler, and D. W. Miller
COMPARISON OF DRUG EFFLUX TRANSPORT KINETICS IN VARIOUS BLOOD-BRAIN BARRIER MODELS
Drug Metab. Dispos., June 1, 2006; 34(6): 998 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
S. Dallas, D. S. Miller, and R. Bendayan
Multidrug resistance-associated proteins: expression and function in the central nervous system.
Pharmacol. Rev., June 1, 2006; 58(2): 140 - 161.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
L. Couture, J. A. Nash, and J. Turgeon
The ATP-Binding Cassette Transporters and Their Implication in Drug Disposition: A Special Look at the Heart.
Pharmacol. Rev., June 1, 2006; 58(2): 244 - 258.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
S. Yamaguchi, Y. L. Zhao, M. Nadai, H. Yoshizumi, X. Cen, S. Torita, K. Takagi, K. Takagi, and T. Hasegawa
Involvement of the Drug Transporters P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 in Telithromycin Transport
Antimicrob. Agents Chemother., January 1, 2006; 50(1): 80 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
J. M. Maher, A. L. Slitt, N. J. Cherrington, X. Cheng, and C. D. Klaassen
TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
Drug Metab. Dispos., July 1, 2005; 33(7): 947 - 955.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
A. Pichler, N. Zelcer, J. L. Prior, A. J. Kuil, and D. Piwnica-Worms
In vivo RNA Interference-Mediated Ablation of MDR1 P-Glycoprotein
Clin. Cancer Res., June 15, 2005; 11(12): 4487 - 4494.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
S. Pratt, R. L. Shepard, R. A. Kandasamy, P. A. Johnston, W. Perry III, and A. H. Dantzig
The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites
Mol. Cancer Ther., May 1, 2005; 4(5): 855 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
N. Nakatsu, Y. Yoshida, K. Yamazaki, T. Nakamura, S. Dan, Y. Fukui, and T. Yamori
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays
Mol. Cancer Ther., March 1, 2005; 4(3): 399 - 412.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
C. Riganti, E. Miraglia, D. Viarisio, C. Costamagna, G. Pescarmona, D. Ghigo, and A. Bosia
Nitric Oxide Reverts the Resistance to Doxorubicin in Human Colon Cancer Cells by Inhibiting the Drug Efflux
Cancer Res., January 15, 2005; 65(2): 516 - 525.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
G. Jedlitschky, K. Tirschmann, L. E. Lubenow, H. K. Nieuwenhuis, J. W. N. Akkerman, A. Greinacher, and H. K. Kroemer
The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage
Blood, December 1, 2004; 104(12): 3603 - 3610.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z. E. Sauna, K. Nandigama, and S. V. Ambudkar
Multidrug Resistance Protein 4 (ABCC4)-mediated ATP Hydrolysis: EFFECT OF TRANSPORT SUBSTRATES AND CHARACTERIZATION OF THE POST-HYDROLYSIS TRANSITION STATE
J. Biol. Chem., November 19, 2004; 279(47): 48855 - 48864.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Zhang, J. D. Schuetz, W. F. Elmquist, and D. W. Miller
Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells
J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 449 - 455.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. H. Wright and W. H. Dantzler
Molecular and Cellular Physiology of Renal Organic Cation and Anion Transport
Physiol Rev, July 1, 2004; 84(3): 987 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Inoue, T. Otsuki, A. Hirasawa, I. Imoto, Y. Matsuo, S. Shimizu, M. Taniwaki, and J. Inazawa
Overexpression of PDZK1 within the 1q12-q22 Amplicon Is Likely To Be Associated with Drug-Resistance Phenotype in Multiple Myeloma
Am. J. Pathol., July 1, 2004; 165(1): 71 - 81.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
M. Sugie, E. Asakura, Y. L. Zhao, S. Torita, M. Nadai, K. Baba, K. Kitaichi, K. Takagi, K. Takagi, and T. Hasegawa
Possible Involvement of the Drug Transporters P Glycoprotein and Multidrug Resistance-Associated Protein Mrp2 in Disposition of Azithromycin
Antimicrob. Agents Chemother., March 1, 2004; 48(3): 809 - 814.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
F. Gennuso, C. Fernetti, C. Tirolo, N. Testa, F. L'Episcopo, S. Caniglia, M. C. Morale, J. D. Ostrow, L. Pascolo, C. Tiribelli, et al.
Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1)
PNAS, February 24, 2004; 101(8): 2470 - 2475.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
P. K. Smitherman, A. J. Townsend, T. E. Kute, and C. S. Morrow
Role of Multidrug Resistance Protein 2 (MRP2, ABCC2) in Alkylating Agent Detoxification: MRP2 Potentiates Glutathione S-Transferase A1-1-Mediated Resistance to Chlorambucil Cytotoxicity
J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 260 - 267.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
P. Dazert, K. Meissner, S. Vogelgesang, B. Heydrich, L. Eckel, M. Bohm, R. Warzok, R. Kerb, U. Brinkmann, E. Schaeffeler, et al.
Expression and Localization of the Multidrug Resistance Protein 5 (MRP5/ABCC5), a Cellular Export Pump for Cyclic Nucleotides, in Human Heart
Am. J. Pathol., October 1, 2003; 163(4): 1567 - 1577.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
G. D. Leonard, T. Fojo, and S. E. Bates
The Role of ABC Transporters in Clinical Practice
Oncologist, October 1, 2003; 8(5): 411 - 424.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Reid, P. Wielinga, N. Zelcer, I. van der Heijden, A. Kuil, M. de Haas, J. Wijnholds, and P. Borst
The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs
PNAS, August 5, 2003; 100(16): 9244 - 9249.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
J E Ros, T A D Roskams, M Geuken, R Havinga, P L Splinter, B E Petersen, N F LaRusso, D M van der Kolk, F Kuipers, K N Faber, et al.
ATP binding cassette transporter gene expression in rat liver progenitor cells
Gut, July 1, 2003; 52(7): 1060 - 1067.
[Abstract] [Full Text]

Home page
 Molecular Cancer TherapeuticsHome page
A. C. Lockhart, R. G. Tirona, and R. B. Kim
Pharmacogenetics of ATP-binding Cassette Transporters in Cancer and Chemotherapy
Mol. Cancer Ther., July 1, 2003; 2(7): 685 - 698.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
F. Mayer, F. Honecker, L. H. J. Looijenga, and C. Bokemeyer
Towards an understanding of the biological basis of response to cisplatin-based chemotherapy in germ-cell tumors
Ann. Onc., June 1, 2003; 14(6): 825 - 832.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
R O. Elferink
Cholestasis
Gut, May 1, 2003; 52(90002): ii42 - 48.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
I.-S. Song, Y.-M. Lee, S.-J. Chung, and C.-K. Shim
Multiple Alterations of Canalicular Membrane Transport Activities in Rats with CCl4-induced Hepatic Injury
Drug Metab. Dispos., April 1, 2003; 31(4): 482 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
O. Kocher, R. Pal, M. Roberts, C. Cirovic, and A. Gilchrist
Targeted Disruption of the PDZK1 Gene by Homologous Recombination
Mol. Cell. Biol., February 15, 2003; 23(4): 1175 - 1180.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. J. Oleschuk, R. G. Deeley, and S. P. C. Cole
Substitution of Trp1242 of TM17 alters substrate specificity of human multidrug resistance protein 3
Am J Physiol Gastrointest Liver Physiol, February 1, 2003; 284(2): G280 - G289.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. K. Lamba, M. Adachi, D. Sun, J. Tammur, E. G. Schuetz, R. Allikmets, and J. D. Schuetz
Nonsense mediated decay downregulates conserved alternatively spliced ABCC4 transcripts bearing nonsense codons
Hum. Mol. Genet., January 15, 2003; 12(2): 99 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
Y. Xu and M. A. Villalona-Calero
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
Ann. Onc., December 1, 2002; 13(12): 1841 - 1851.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
P. R. Wielinga, G. Reid, E. E. Challa, I. van der Heijden, L. van Deemter, M. de Haas, C. Mol, A. J. Kuil, E. Groeneveld, J. D. Schuetz, et al.
Thiopurine Metabolism and Identification of the Thiopurine Metabolites Transported by MRP4 and MRP5 Overexpressed in Human Embryonic Kidney Cells
Mol. Pharmacol., December 1, 2002; 62(6): 1321 - 1331.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Y. Ohishi, Y. Oda, T. Uchiumi, H. Kobayashi, T. Hirakawa, S. Miyamoto, N. Kinukawa, H. Nakano, M. Kuwano, and M. Tsuneyoshi
ATP-binding Cassette Superfamily Transporter Gene Expression in Human Primary Ovarian Carcinoma
Clin. Cancer Res., December 1, 2002; 8(12): 3767 - 3775.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
D. Burg, P. Wielinga, N. Zelcer, T. Saeki, G. J. Mulder, and P. Borst
Inhibition of the Multidrug Resistance Protein 1 (MRP1) by Peptidomimetic Glutathione-Conjugate Analogs
Mol. Pharmacol., November 1, 2002; 62(5): 1160 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-M. Qian, C. E. Grant, C. J. Westlake, D.-W. Zhang, P. A. Lander, R. L. Shepard, A. H. Dantzig, S. P. C. Cole, and R. G. Deeley
Photolabeling of Human and Murine Multidrug Resistance Protein 1 with the High Affinity Inhibitor [125I]LY475776 and Azidophenacyl-[35S]Glutathione
J. Biol. Chem., September 13, 2002; 277(38): 35225 - 35231.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
J. Cao, B. Stieger, P. J. Meier, and M. Vore
Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy
Am J Physiol Gastrointest Liver Physiol, September 1, 2002; 283(3): G757 - G766.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
R. Yan and E. M. Taylor
Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters
Drug Metab. Dispos., May 1, 2002; 30(5): 513 - 518.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
K. L. Audus, M. J. Soares, and J. S. Hunt
Characteristics of the Fetal/Maternal Interface with Potential Usefulness in the Development of Future Immunological and Pharmacological Strategies
J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 402 - 409.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
G L Scheffer, A C L M Pijnenborg, E F Smit, M Muller, D S Postma, W Timens, P van der Valk, E G E de Vries, and R J Scheper
Multidrug resistance related molecules in human and murine lung
J. Clin. Pathol., May 1, 2002; 55(5): 332 - 339.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. Tanaka, Y. Kobayashi, E. C. Gabazza, K. Higuchi, T. Kamisako, M. Kuroda, K. Takeuchi, M. Iwasa, M. Kaito, and Y. Adachi
Increased renal expression of bilirubin glucuronide transporters in a rat model of obstructive jaundice
Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G656 - G662.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
D. Rost, S. Mahner, Y. Sugiyama, and W. Stremmel
Expression and localization of the multidrug resistance-associated protein 3 in rat small and large intestine
Am J Physiol Gastrointest Liver Physiol, April 1, 2002; 282(4): G720 - G726.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. A. M. H. van Aubel, P. H. E. Smeets, J. G. P. Peters, R. J. M. Bindels, and F. G. M. Russel
The MRP4/ABCC4 Gene Encodes a Novel Apical Organic Anion Transporter in Human Kidney Proximal Tubules: Putative Efflux Pump for Urinary cAMP and cGMP
J. Am. Soc. Nephrol., March 1, 2002; 13(3): 595 - 603.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
G. M. Williams and M. J. Iatropoulos
Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity
Toxicol Pathol, January 1, 2002; 30(1): 41 - 53.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
A. Inokuchi, E. Hinoshita, Y. Iwamoto, K. Kohno, M. Kuwano, and T. Uchiumi
Enhanced Expression of the Human Multidrug Resistance Protein 3 by Bile Salt in Human Enterocytes. A TRANSCRIPTIONAL CONTROL OF A PLAUSIBLE BILE ACID TRANSPORTER
J. Biol. Chem., December 7, 2001; 276(50): 46822 - 46829.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Zelcer, T. Saeki, G. Reid, J. H. Beijnen, and P. Borst
Characterization of Drug Transport by the Human Multidrug Resistance Protein 3 (ABCC3)
J. Biol. Chem., November 30, 2001; 276(49): 46400 - 46407.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Taipalensuu, H. Tornblom, G. Lindberg, C. Einarsson, F. Sjoqvist, H. Melhus, P. Garberg, B. Sjostrom, B. Lundgren, and P. Artursson
Correlation of Gene Expression of Ten Drug Efflux Proteins of the ATP-Binding Cassette Transporter Family in Normal Human Jejunum and in Human Intestinal Epithelial Caco-2 Cell Monolayers
J. Pharmacol. Exp. Ther., October 1, 2001; 299(1): 164 - 170.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
K. Ito, H. Suzuki, and Y. Sugiyama
Single amino acid substitution of rat MRP2 results in acquired transport activity for taurocholate
Am J Physiol Gastrointest Liver Physiol, October 1, 2001; 281(4): G1034 - G1043.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Zeng, Z.-S. Chen, M. G. Belinsky, P. A. Rea, and G. D. Kruh
Transport of Methotrexate (MTX) and Folates by Multidrug Resistance Protein (MRP) 3 and MRP1: Effect of Polyglutamylation on MTX Transport
Cancer Res., October 1, 2001; 61(19): 7225 - 7232.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Z. Khokhar, Y. She, V. W. Rusch, and F. M. Sirotnak
Experimental Therapeutics with a New 10-Deazaaminopterin in Human Mesothelioma: Further Improving Efficacy through Structural Design, Pharmacologic Modulation at the Level of MRP ATPases, and Combined Therapy with Platinums
Clin. Cancer Res., October 1, 2001; 7(10): 3199 - 3205.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Yamada, K. Kawano, M. Koga, T. Matsumoto, and K. Itoh
Multidrug Resistance-associated Protein 3 Is a Tumor Rejection Antigen Recognized by HLA-A2402-restricted Cytotoxic T Lymphocytes
Cancer Res., September 1, 2001; 61(17): 6459 - 6466.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. C. Young, B. G. Campling, S. P. C. Cole, R. G. Deeley, and J. H. Gerlach
Multidrug Resistance Proteins MRP3, MRP1, and MRP2 in Lung Cancer: Correlation of Protein Levels with Drug Response and Messenger RNA Levels
Clin. Cancer Res., June 1, 2001; 7(6): 1798 - 1804.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Ito, H. Suzuki, and Y. Sugiyama
Charged Amino Acids in the Transmembrane Domains Are Involved in the Determination of the Substrate Specificity of Rat Mrp2
Mol. Pharmacol., April 16, 2001; 59(5): 1077 - 1085.
[Abstract] [Full Text]

Home page
 Cancer Res.Home page
M. Maliepaard, G. L. Scheffer, I. F. Faneyte, M. A. van Gastelen, A. C. L. M. Pijnenborg, A. H. Schinkel, M. J. van de Vijver, R. J. Scheper, and J. H. M. Schellens
Subcellular Localization and Distribution of the Breast Cancer Resistance Protein Transporter in Normal Human Tissues
Cancer Res., April 1, 2001; 61(8): 3458 - 3464.
[Abstract] [Full Text]

Home page
 JNCI J Natl Cancer InstHome page
K. Lee, A. J. P. Klein-Szanto, and G. D. Kruh
Analysis of the MRP4 Drug Resistance Profile in Transfected NIH3T3 Cells
J Natl Cancer Inst, December 6, 2000; 92(23): 1934 - 1940.
[Abstract] [Full Text] [PDF]

Home page